| CUP-AI-Dx: A tool for inferring cancer tissue of origin and molecular subtype using RNA gene-expression data and artificial intelligence Y Zhao, Z Pan, S Namburi, A Pattison, A Posner, S Balachander, ... EBioMedicine 61, 2020 | 82 | 2020 |
| Alternative polyadenylation in the regulation and dysregulation of gene expression RE Turner, AD Pattison, TH Beilharz Seminars in cell & developmental biology 75, 61-69, 2018 | 68 | 2018 |
| Topconfects: a package for confident effect sizes in differential expression analysis provides a more biologically useful ranked gene list PF Harrison, AD Pattison, DR Powell, TH Beilharz Genome biology 20, 1-12, 2019 | 49 | 2019 |
| Functional and genomic characterisation of a xenograft model system for the study of metastasis in triple-negative breast cancer CN Johnstone, AD Pattison, KL Gorringe, PF Harrison, DR Powell, P Lock, ... Disease models & mechanisms 11 (5), dmm032250, 2018 | 34 | 2018 |
| FGF13 promotes metastasis of triple‐negative breast cancer CN Johnstone, AD Pattison, PF Harrison, DR Powell, P Lock, M Ernst, ... International journal of cancer 147 (1), 230-243, 2020 | 33 | 2020 |
| A xenograft and cell line model of SDH-deficient pheochromocytoma derived from Sdhb+/− rats JF Powers, B Cochran, JD Baleja, HD Sikes, AD Pattison, X Zhang, ... Endocrine-Related Cancer 27 (6), 337-354, 2020 | 33 | 2020 |
| γδ T cells in merkel cell carcinomas have a proinflammatory profile prognostic of patient survival NA Gherardin, K Waldeck, A Caneborg, LG Martelotto, S Balachander, ... Cancer immunology research 9 (6), 612-623, 2021 | 28 | 2021 |
| Single-nuclei and bulk-tissue gene-expression analysis of pheochromocytoma and paraganglioma links disease subtypes with tumor microenvironment M Zethoven, L Martelotto, A Pattison, B Bowen, S Balachander, A Flynn, ... Nature Communications 13 (1), 6262, 2022 | 27 | 2022 |
| A comparison of DNA sequencing and gene expression profiling to assist tissue of origin diagnosis in cancer of unknown primary A Posner, OW Prall, T Sivakumaran, D Etemadamoghadam, N Thio, ... The Journal of pathology 259 (1), 81-92, 2023 | 13 | 2023 |
| Clinical, FDG-PET and molecular markers of immune checkpoint inhibitor response in patients with metastatic Merkel cell carcinoma AM Weppler, A Pattison, P Bhave, P De Ieso, J Raleigh, A Hatzimihalis, ... Journal for Immunotherapy of Cancer 8 (2), 2020 | 11 | 2020 |
| Novel RET Fusion RET-SEPTIN9 Predicts Response to Selective RET Inhibition With Selpercatinib in Malignant Pheochromocytoma A Mweempwa, H Xu, JHA Vissers, RW Tothill, AD Pattison, AP Fellowes, ... JCO Precision Oncology 5, 1160-1165, 2021 | 9 | 2021 |
| Annexin A1 is required for efficient tumor initiation and cancer stem cell maintenance in a model of human breast cancer CN Johnstone, Y Tu, S Langenbach, D Baloyan, AD Pattison, P Lock, ... Cancers 13 (5), 1154, 2021 | 9 | 2021 |
| Immune and genomic biomarkers of immunotherapy response in cancer of unknown primary A Posner, T Sivakumaran, A Pattison, D Etemadmoghadam, N Thio, ... Journal for Immunotherapy of Cancer 11 (1), 2023 | 6 | 2023 |
| Widespread cytoplasmic polyadenylation programs asymmetry in the germline and early embryo PR Boag, PF Harrison, AA Barugahare, AD Pattison, A Swaminathan, ... bioRxiv, 428540, 2018 | 3 | 2018 |
| Author Correction: Single-nuclei and bulk-tissue gene-expression analysis of pheochromocytoma and paraganglioma links disease subtypes with tumor microenvironment M Zethoven, L Martelotto, A Pattison, B Bowen, S Balachander, A Flynn, ... Nature communications 14, 2023 | 2 | 2023 |
| Identifying biomarkers to guide immunotherapy treatment of cancer of unknown primary. LR Mileshkin, A Posner, A Pattison, S Balachander, D Etemadmoghadam, ... Journal of Clinical Oncology 38 (15_suppl), e15252-e15252, 2020 | 2 | 2020 |
| Topconfects: a package for confident effect sizes in differential expression analysis provides improved usability ranking genes of interest PF Harrison, AD Pattison, DR Powell, TH Beilharz bioRxiv, 343145, 2018 | 1 | 2018 |
| Multi-omic analysis of SDHB-deficient pheochromocytomas and paragangliomas identifies metastasis and treatment-related molecular profiles R Tothill, A Flynn, A Pattison, S Balachander, E Boehm, B Bowen, ... | | 2024 |
| DNA sequencing and gene-expression profiling assists in making a tissue of origin diagnosis in cancer of unknown primary A Posner, OWJ Prall, T Sivakumaran, D Etemadamoghadam, N Thio, ... medRxiv, 2022.06. 24.22276729, 2022 | | 2022 |
| Clinical and FDG-PET markers of immune checkpoint inhibitor (ICI) response in patients with metastatic Merkel cell carcinoma (mMCC) AM Weppler, P Bhave, P De Ieso, M Chua, J Raleigh, A Hatzimihalis, ... Annals of Oncology 30, ix115, 2019 | | 2019 |
